Bill
A 6927
Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy
2025 Regular Session
Introduced by Harry Bronson and 11 co-sponsors
Bill A 6927 mandates clearer prescription labels for hormone-related medications, enhancing patient safety and education to improve treatment adherence and health outcomes.
REFERRED TO HIGHER EDUCATION